
https://angel.co/medsender
Location: United States, New York
Employees: 1-10
Phone: +1 347-966-4439
Total raised: $5M
Funding Rounds 1
Date | Series | Amount | Investors |
18.02.2025 | Series A | $5M | - |
Mentions in press and media 6
Date | Title | Description |
18.02.2025 | Medsender: $5 Million (Series A) Raised For Transforming Healthcare | Medsender, an AI-based workflow automation platform for healthcare providers, announced a recent $5 million Series A investment led by Ballast Point Ventures. And Medsender will use the funding to bolster its commercial team, accelerate its... |
01.02.2025 | Medsender's $5M Boost: A Leap Towards Healthcare Efficiency | In the bustling landscape of healthcare, where every second counts, Medsender has emerged as a beacon of innovation. The New York City-based company recently secured $5 million in Series A funding, led by Ballast Point Ventures. This financ... |
01.02.2025 | Medsender: AI-Based Workflow Automation Company Closes $5 Million (Series A) | Medsender, an AI-based workflow automation platform for healthcare providers, announced a recent $5 million Series A investment led by Ballast Point Ventures. And Medsender will use the funding to support its commercial team, accelerate its... |
31.01.2025 | Medsender Raises $5M for AI-Powered Workflow Automation Platform | What You Should Know: – Medsender, the AI-powered workflow automation platform for healthcare providers, is pleased to announce a recent $5 million Series A investment led by Ballast Point Ventures. – Medsender will use the investment to bo... |
30.01.2025 | Medsender Raises $5M in Series A Funding | Medsender, a NYC-based provider of an AI-powered workflow automation platform for healthcare providers, raised $5M in Series A funding. The round was led by Ballast Point Ventures. The company intends to use the funds to bolster its commerc... |
- | Medsender | “HIPAA-compliant fax, forms, and document automation that integrates with your EMR. Medsender is an easy-to-use platform loved by healthcare providers.” |